Carlsmed, Inc.

CARL Healthcare Health Information Services

Carlsmed, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $50.5 million, up 85.9% from fiscal 2024. In the quarter to June 2026, revenue grew 56.8%, EPS grew 73.5%, free cash flow fell 6.84% and total debt was flat, each against the same quarter a year earlier.

13.41 0.54 −3.87%
Market cap
$380.9M
P/E
0.0×
Fwd P/E
−7.4×
Dividend yield
—
F-score
n/a
Altman Z
2.94
Beneish M
−1.77
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Older periods Sep '25 Dec '25 Mar '26 Jun '26
Total current assets
131.47 126.67 115.41 109.60
Total non-current assets
3.40 3.45 3.36 8.60
Total Assets
134.86 130.12 118.77 118.20
Total current liabilities
10.93 14.28 9.72 12.40
Total non-current liabilities
17.28 16.97 16.81 21.56
Total liabilities
28.20 31.25 26.52 33.96
Common Equity (Total)
106.66 98.87 92.25 84.25
Shareholders Equity (Total)
106.66 98.87 92.25 84.25
Total Debt
15.44 15.35 15.36 15.38

Show all line items

In millions of $ except per-share values · columns are period end dates